Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Patterson Companies investors underwhelmed by 'in-line' earnings

Patterson Companies, Inc. (NASDAQ:PDCO) shares fell more than 6% in early trading on Wednesday after the animal and oral health markets solutions provider reported its first quarter fiscal 2024 financial results.

Its sales for the period rose 3.5% year-over-year to $1.57 billion, matching the Street forecast per Zacks Consensus Estimate.

Adjusted earnings per share of $0.40 were in line with analysts’ expectations too and represented a 25% increase over the year-ago quarter.

Investors may also have been left disappointed by the fact that the company did not raise its outlook, reiterating its 2024 earnings guidance of $2.14 to $2.24 per share and adjusted earnings guidance of $2.45 to $2.55 per share.

Patterson Companies shares were down 6.5% at US$31.16 shortly after the opening bell in New York.

Contact the author at emily.jarvie@proactiveinvestors.com

Follow her on Twitter @emilyjjarvie

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK